title: Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression.
authors.affiliation: Department of Urology, Tokyo Women's Medical University, Japan.
authors.forename: M A
authors.initials: MA
authors.lastname: Manu
authors.forename: K
authors.initials: K
authors.lastname: Tanabe
authors.forename: N
authors.initials: N
authors.lastname: Ishikawa
authors.forename: T
authors.initials: T
authors.lastname: Tokumoto
authors.forename: T
authors.initials: T
authors.lastname: Oshima
authors.forename: H
authors.initials: H
authors.lastname: Shinmura
authors.forename: M
authors.initials: M
authors.lastname: Harano
authors.forename: S
authors.initials: S
authors.lastname: Otsubo
authors.forename: M
authors.initials: M
authors.lastname: Inui
authors.forename: A
authors.initials: A
authors.lastname: Kanematsu
authors.forename: S
authors.initials: S
authors.lastname: Fuchinoue
authors.forename: H
authors.initials: H
authors.lastname: Toma
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001787:Blood Group Incompatibility; D002908:Chronic Disease; D016572:Cyclosporine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005922:Glomerulonephritis, IGA / Q000139:chemically induced*; D006084:Graft Rejection / Q000188:drug therapy*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone